Journals in Laboratory medicine

Advances in Biomarker Sciences and Technology

ISSN: 2543-1064

Advances in Biomarker Sciences and Technology (ABST) is a rigorously peer-reviewed, fully open access journal that aims to encompass all aspects of biomarker research, from biomarker development to its applications, clinical diagnosis and treatment to molecular epidemiology and toxicology; from precision medicine to drug development, and from nanotechnology to bioinformatics. ABST focuses on building upon the next generation of biomarkers to accelerate communication of the latest advances in their identification as well as applications. We strive to achieve this objective by providing a high-quality forum for the publication of biomarker-related investigations, including (but not limited to) general research articles elucidating topics in novel technologies, study designs or mathematical models, invited and selected reviews, short communications and editorials.Editorial Board

Clinics in Laboratory Medicine

ISSN: 0272-2712
5 Year impact factor: 1.9
Impact factor: 1.7

Clinics in Laboratory Medicine updates those practicing in the field of clinical pathology on the latest trends in clinical laboratory management, providing a sound basis for creating and working in a highly effective clinical laboratory. Published quarterly—in March, June, September, and December—each issue offers state-of-the-art reviews on a single topic in pathology, including quality control in lab testing, coagulation, clinical microbiology, toxicology testing, clinical cytogenetics, mass spectrometry, blood transfusion, and much more.

Digital Chinese Medicine

ISSN: 2589-3777

Digital Chinese Medicine (DCM) is a new, quarterly, open-access global publication, officially funded by the Project for Enhancing the International Impact of China STM Journals —2016.With the aim of promoting the combination of TCM (Traditional Chinese Medicine) and modern information science and realizing modernization, this new journal provides an important platform for the communication of scientific and technological TCM.Spanning all aspects in the multidisciplinary fields of TCM, Chinese materia medica, and computer and information sciences, this journal publishes a range of article types, including highlights, reviews, and original research.Editorial Board

Heliyon

ISSN: 2405-8440
5 Year impact factor: 3.9
Impact factor: 3.4

Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

Journal of Mass Spectrometry and Advances in the Clinical Lab

ISSN: 2376-9998
5 Year impact factor: 3.1
Impact factor: 3.1

Official Journal of MSACLThe Journal of Mass Spectrometry and Advances in the Clinical Lab (JMSACL, formerly known as Clinical Mass Spectrometry) is an open access, pay-what-you-can journal and publishes peer-reviewed articles addressing mass spectrometry and other advances in Laboratory Medicine and Pathology with a focus on development of diagnostic and related applications, including data science, to improve patient outcomes and reduce healthcare costs.Beyond communication of the application of technologies in the routine clinical diagnostic setting, by publishing critically validated analytical protocols, the journal also addresses the translation of experimental techniques and analytical research into patient care, and the use of these technologies in clinical research and routine patient management. The scope of the journal is not restricted to any particular technology, but covers the entire range of technologies and advancements that are expected to impact the clinical lab.The journal encourages submissions having a clear path to patient care, including basic and translational research, and animal studies.Subject areas covered by the journal include, but are not restricted to:AutomationClinical Studies and ImplementationCross-Technology InvestigationsData ScienceEndocrinologyError Sources, Risk Assessment and Patient SafetyGlycomicsHarmonization and StandardizationImagingInstrumentationLipidomicsMetabolomics and Metabolic AnalysesMethod Development and ValidationMetrologyMicrobiologyNeonatal ScreeningNew TechnologiesPoint-of-Care TechnologiesProtein QuantificationProtein Variant DetectionProteomicsQuality ManagementReference Methods and MaterialsRegulatory Aspects in Diagnostic ApplicationsSample PreparationSeparation ScienceSmall MoleculesTherapeutic Drug MonitoringToxicologyTypes of papers: Reviews, graphical reviews, mini-reviews, original research papers, short communications (e.g., letters, case studies, protocols, application notes, developed poster presentations), guidelines and best practice documents, tutorials, invited editorials, opinions.

Journal of the American Society of Cytopathology

ISSN: 2213-2945

JASC is the official journal of the American Society of Cytopathology,and reflects the values and priorities of the society. JASC publishes regular bimonthly issues with cutting-edge original research of the highest standard. The Journal seeks to provide an exceptional forum for interaction and dissemination of original research and educational information in the field of cytopathology and other allied disciplines in medicine. The cross-disciplinary focus of the journal ensures the sharing of information with all readers involved in the practice of cytopathology and its related basic sciences, epidemiology and clinical oncologic disciplines.JASC endeavors to have a positive impact not only on all aspects of cancer diagnosis and treatment, but also on other human disease. JASC publishes original work emphasizing novel discoveries or clinicopathologic correlations in a patient-centered environment, technological advances in basic and translational research with emphasis on the development of personalized medicine, and new or improved molecular techniques and their novel application for diagnosis or monitoring of disease. Preference is also given to original work demonstrating the scholarship of education in cytopathology including new innovative tools for continuing education and training as well as designing and implementing new assessment and evaluation techniques. It duly addresses and highlights issues relating to population health and public policy topics. It is the goal of JASC to lead the discipline of cytopathology by setting professional quality standards ensuring diagnostic excellence, advocating laboratory safety and quality, and inter-professional education for pathologists, cytotechnologists and all allied health care specialties.

Practical Laboratory Medicine

ISSN: 2352-5517
5 Year impact factor: 1.7
Impact factor: 1.7

Practical Laboratory Medicine is a high-quality, peer-reviewed, international open-access journal publishing original research, new methods and critical evaluations, case reports and short papers in the fields of clinical chemistry and laboratory medicine.The objective of the journal is to provide practical information of immediate relevance to workers in clinical laboratories. The primary scope of the journal covers clinical chemistry, hematology, molecular biology and genetics relevant to laboratory medicine, microbiology, immunology, therapeutic drug monitoring and toxicology, laboratory management and informatics.We welcome papers which describe critical evaluations of biomarkers and their role in the diagnosis and treatment of clinically significant disease, validation of commercial and in-house IVD methods, method comparisons, interference reports, the development of new reagents and reference materials, reference range studies and regulatory compliance reports. Manuscripts describing the development of new methods applicable to laboratory medicine (including point-of-care testing) are particularly encouraged, even if preliminary or small scale.While novel or innovative work is preferred, papers of a confirmatory nature will also be considered if they are scientifically and technically valid and relevant to important topics.

The American Journal of the Medical Sciences

ISSN: 0002-9629
5 Year impact factor: 2.4
Impact factor: 2.3

Mission Statement: The mission of The American Journal of the Medical Sciences (AJMS) is to support the exchange of knowledge and information and to publish high quality clinical, basic, and education research. As the official Journal of the Southern Society for Clinical Investigation (SSCI), an academic organization, The AJMS will support the academic, educational, and medical research activities of the SSCI through the exchange of knowledge, information and ideas at the Southern Regional Meetings. Through these activities, the Journal will actively support mentoring, research activities and the scholarship of future generations of medical academicians.Vision Statement: The American Journal of the Medical Sciences will be recognized as a premier medical journal for showcasing basic and clinical medical research, and advances in medical education. The American Journal of the Medical Sciences is the official Journal of the Southern Society for Clinical Investigation (SSCI) and is dedicated to supporting the academic agenda of the SSCI. The AJMS is committed to supporting and encouraging young investigators, mentoring future generations of these investigators, and promoting their careers in academic medicine.The American Journal of The Medical Sciences (AJMS), founded in 1820, is the 2nd oldest medical journal in the United States. The AJMS is the official journal of the Southern Society for Clinical Investigation (SSCI). The SSCI is dedicated to the advancement of medical research and the exchange of knowledge, information and ideas. Its members are committed to mentoring future generations of medical investigators and promoting careers in academic medicine. The AJMS publishes, on a monthly basis, peer-reviewed articles in the field of internal medicine and its subspecialties, which include:Original clinical and basic science investigationsReview articlesOnline Images in the Medical SciencesSpecial Features Include:Patient-Centered Focused ReviewsHistory of MedicineThe Science of Medical Education

The Journal of Molecular Diagnostics

ISSN: 1525-1578
5 Year impact factor: 3.9
Impact factor: 3.4

Official journal of the Association for Molecular Pathology (AMP)The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods which may be applied to diagnosis or monitoring of disease or disease predisposition.

URINE

ISSN: 2590-2806

URINE promotes basic research, translation and clinical applications in the area of urine, with the aim of improving understanding, screening, diagnosis, treatment monitoring and disease management. The journal not only accelerates the development of research in this field but helps to build connections between the diverse communities involved in urine research.The next generation of biomarker is projected to rely heavily upon urinary biomarkers to stratify risk, diagnose disease, determine optimal treatment strategies, evaluate drug response and monitor disease progression.These objectives are achieved by providing a fast, author-focused publication process. All types of papers are welcome, and each submission benefits from expert peer-review. To protect the novelty of authors, URINE encourages and welcomes the submission of manuscripts that have already been posted on a preprint archive.Submissions on a variety of urine-related topics will be considered. These include, but are not limited to, papers addressing:Urinary biomarker discovery and validation and the development of various systematic diseases.Disease development observations from changes in urine.Screening for early signs of pathophysiological processes in the body.Disease management and treatment based on early diagnosis of the diseases in urine.Technological developments that can potentially be applied to the field of urine, either in basic research or clinical applications, for example, biobanking methods of various urine components.Bioinformatics related to urinary biomarker studies.Urinary extracellular vesiclesUrinary-based liquid biopsiesIn recognition of the breadth of the research communities active in biomarker studies, the URINE Executive Editorial board will consist of four types of researchers at all times:Clinical domain expertsExperts in physiology, biology, biochemistry and related disciplinesStatistical and experimental design expertsEngineering expertsThis will help to ensure that the journal can reliably evaluate a range of studies and maintain a diverse collection of articles.

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health